CAS: 1133819-87-0
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
MSDC 0602 REF: IN-DA00IMP7CAS: 1133819-87-0 | % | To inquire | Tue 10 Dec 24 | |
Azemiglitazone REF: TM-T4639CAS: 1133819-87-0 | 97.02% - 99.6% | 57.00 €~1,112.00 € | Tue 17 Dec 24 | |
MSDC 0602 REF: TR-M755420CAS: 1133819-87-0 | - - - | 135.00 €~502.00 € | Tue 21 Jan 25 | |
MSDC-0602 REF: 3D-IVB81987CAS: 1133819-87-0 | Min. 95% | To inquire | Tue 21 Jan 25 |
Ref: IN-DA00IMP7
5mg | 113.00 € | ||
10mg | 141.00 € | ||
25mg | 183.00 € | ||
50mg | 309.00 € | ||
100mg | 495.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Azemiglitazone
CAS:1133819-87-0
Azemiglitazone (MSDC 0602) is an insulin sensitizer potentially for the treatment of diabetes.
Formula:
C19H17NO5S
Purity:
97.02% - 99.6%
Color and Shape:
Solid
Molecular weight:
371.41
Ref: TM-T4639
5mg | 57.00 € | ||
10mg | 83.00 € | ||
25mg | 158.00 € | ||
50mg | 279.00 € | ||
100mg | 515.00 € | ||
500mg | 1,112.00 € | ||
1mL*10mM (DMSO) | 63.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
MSDC 0602
Controlled ProductCAS:1133819-87-0
Formula:
C19H17NO5S
Color and Shape:
Neat
Molecular weight:
371.41
Ref: TR-M755420
10mg | 135.00 € | ||
25mg | 261.00 € | ||
50mg | 502.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
MSDC-0602
CAS:1133819-87-0
MSDC-0602 is a novel antidiabetic drug that has been shown to inhibit the uptake of …
Formula:
C19H17NO5S
Purity:
Min. 95%
Molecular weight:
371.41 g/mol
Ref: 3D-IVB81987
100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025